HPLC as a Complimentary Technique to Quantify Bevacizumab

Abstract:

In this application note, we provide a simple, rapid, and low-cost method for the quantification of Bevacizumab formulated in HSA-based nanoparticles using a Biozen 3 µm dSEC-2 HPLC Column.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical

Techniques:

HPLC / UHPLC

Brands:

bioZen

PDF Link:

Click here